Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Lamotrigine clinical pharmacokinetics.

Rambeck B, Wolf P.

Clin Pharmacokinet. 1993 Dec;25(6):433-43. Review.

PMID:
8119045
2.

Clinical pharmacokinetics of oxcarbazepine.

May TW, Korn-Merker E, Rambeck B.

Clin Pharmacokinet. 2003;42(12):1023-42. Review.

PMID:
12959634
3.

Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy.

Grasela TH, Fiedler-Kelly J, Cox E, Womble GP, Risner ME, Chen C.

J Clin Pharmacol. 1999 Apr;39(4):373-84.

PMID:
10197296
4.

Lamotrigine drug interactions in a TDM material.

Böttiger Y, Svensson JO, Ståhle L.

Ther Drug Monit. 1999 Apr;21(2):171-4.

PMID:
10217336
6.

Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.

Perucca E, Cloyd J, Critchley D, Fuseau E.

Epilepsia. 2008 Jul;49(7):1123-41. doi: 10.1111/j.1528-1167.2008.01665.x.

7.
8.

Impact of age, weight and concomitant treatment on lamotrigine pharmacokinetics.

Brzaković BB, Vezmar Kovačević SD, Vučićević KM, Miljković BR, Martinović ZJ, Pokrajac MV, Prostran MŠ.

J Clin Pharm Ther. 2012 Dec;37(6):693-7. doi: 10.1111/j.1365-2710.2012.01351.x. Epub 2012 May 14.

PMID:
22583007
9.

Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy.

Goa KL, Ross SR, Chrisp P.

Drugs. 1993 Jul;46(1):152-76. Review.

PMID:
7691504
10.

Single-dose pharmacokinetics of lamotrigine in children: influence of age and antiepileptic comedication.

Battino D, Croci D, Granata T, Mamoli D, Messina S, Perucca E.

Ther Drug Monit. 2001 Jun;23(3):217-22.

PMID:
11360028
11.

Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy.

Jawad S, Yuen WC, Peck AW, Hamilton MJ, Oxley JR, Richens A.

Epilepsy Res. 1987 May;1(3):194-201.

PMID:
3504397
12.

Didanosine : An Update on its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Efficacy in the Management of HIV Disease.

Perry CM, Balfour JA.

Drugs. 1996 Dec;52(6):928-962. doi: 10.2165/00003495-199652060-00014.

PMID:
28593572
13.

Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.

Nevitt SJ, Sudell M, Weston J, Tudur Smith C, Marson AG.

Cochrane Database Syst Rev. 2017 Jun 29;6:CD011412. doi: 10.1002/14651858.CD011412.pub2. Review.

PMID:
28661008
14.

Influence of concurrent antiepileptic medication on the pharmacokinetics of lamotrigine as add-on therapy in epileptic children.

Vauzelle-Kervroëdan F, Rey E, Cieuta C, Pariente-Khayat A, Pons G, d'Athis P, Bidault R, Dulac O, Olive G.

Br J Clin Pharmacol. 1996 Apr;41(4):325-30.

15.

Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy.

Eriksson AS, Hoppu K, Nergårdh A, Boreus L.

Epilepsia. 1996 Aug;37(8):769-73.

PMID:
8764817
16.

Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.

Contin M, Riva R, Albani F, Avoni P, Baruzzi A.

Ther Drug Monit. 2002 Jun;24(3):332-7.

PMID:
12021622
17.

The clinical efficacy of lamotrigine as an antiepileptic drug.

Pellock JM.

Neurology. 1994 Nov;44(11 Suppl 8):S29-35. Review.

PMID:
7970004
18.

Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.

Walzer M, Bekersky I, Blum RA, Tolbert D.

Pharmacotherapy. 2012 Apr;32(4):340-53. doi: 10.1002/j.1875-9114.2012.01028.x. Epub 2012 Mar 15.

PMID:
22422635
20.

Pharmacokinetic interactions of the new antiepileptic drugs.

Rambeck B, Specht U, Wolf P.

Clin Pharmacokinet. 1996 Oct;31(4):309-24. Review.

PMID:
8896946

Supplemental Content

Support Center